...
机译:肾细胞癌的基因组分类:朝向泛静脉精度未来适用个性化肾癌护理的关键步骤
Molecular Oncology Department of Medicine Siteman Cancer CenterWashington UniversitySt Louis MO;
Molecular Oncology Department of Medicine Siteman Cancer CenterWashington UniversitySt Louis MO;
Department of PathologyWashington UniversitySt Louis MO USA;
Human Oncology and Pathogenesis ProgramMemorial Sloan Kettering Cancer CenterNew York NY USA;
Human Genome Sequencing Center Department of MedicineBaylor College of MedicineHouston TX USA;
renal cell carcinoma; genomics; transcriptomics; proteomics; metabolomics; biomarkers; targeted therapy; precision therapeutics; personalized medicine;
机译:肾细胞癌的基因组分类:朝向泛静脉精度未来适用个性化肾癌护理的关键步骤
机译:利用癌细胞的基因组特征确定抗癌药物的优先级:迈向个性化医学的一步
机译:利用癌细胞的基因组特征确定抗癌药物的优先级:迈向个性化医学的一步
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:透明细胞肾细胞癌中肉瘤样转化的基因组特征。
机译:透明细胞肾细胞癌(ccRCC)蛋白质组学表征中的挑战和机遇:迈向肾癌个性化护理的关键一步
机译:肾细胞癌的基因组分类:对泛静脉精度的个性化肾癌护理未来应用的关键步骤